KÄÄPÄ Biotech, a biotechnology company specialised in researching, innovating, developing, producing and selling functional mushroom products, today announced the successful closing of a €9,000,000 strategic investment. This milestone underscores the company’s market leading position and highlights the ambitious growth plans in the global nutraceutical market. 

Read the full press release